134 related articles for article (PubMed ID: 3178888)
21. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
Martinson EA; Johnson RA; Wells JN
Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
[TBL] [Abstract][Full Text] [Related]
22. Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Klotz KN; Lohse MJ
J Med Chem; 1988 Jun; 31(6):1179-83. PubMed ID: 3373486
[TBL] [Abstract][Full Text] [Related]
23. 2',3'-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors.
Lohse MJ; Klotz KN; Diekmann E; Friedrich K; Schwabe U
Eur J Pharmacol; 1988 Oct; 156(1):157-60. PubMed ID: 3208837
[TBL] [Abstract][Full Text] [Related]
24. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
25. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
[TBL] [Abstract][Full Text] [Related]
26. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
Choca JI; Proudfit HK; Green RD
J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118
[TBL] [Abstract][Full Text] [Related]
27. Selective activity of bamifylline on adenosine A1-receptors in rat brain.
Abbracchio MP; Cattabeni F
Pharmacol Res Commun; 1987 Aug; 19(8):537-45. PubMed ID: 3432321
[TBL] [Abstract][Full Text] [Related]
28. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
29. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta.
Martin PL; May JM
J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow.
Daly JW; Padgett W; Thompson RD; Kusachi S; Bugni WJ; Olsson RA
Biochem Pharmacol; 1986 Aug; 35(15):2467-81. PubMed ID: 3017353
[TBL] [Abstract][Full Text] [Related]
31. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
32. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
Schwabe U; Ukena D; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
[TBL] [Abstract][Full Text] [Related]
33. Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
Thompson RD; Secunda S; Daly JW; Olsson RA
J Med Chem; 1991 Dec; 34(12):3388-90. PubMed ID: 1766003
[TBL] [Abstract][Full Text] [Related]
34. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
[TBL] [Abstract][Full Text] [Related]
35. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
Zgombick JM; Beck SG; Mahle CD; Craddock-Royal B; Maayani S
Mol Pharmacol; 1989 Apr; 35(4):484-94. PubMed ID: 2495434
[TBL] [Abstract][Full Text] [Related]
36. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
Ukena D; Jacobson KA; Padgett WL; Ayala C; Shamim MT; Kirk KL; Olsson RO; Daly JW
FEBS Lett; 1986 Dec; 209(1):122-8. PubMed ID: 3803571
[TBL] [Abstract][Full Text] [Related]
37. Mesoionic xanthine analogues: antagonists of adenosine receptors.
Glennon RA; Tejani-Butt SM; Padgett W; Daly JW
J Med Chem; 1984 Oct; 27(10):1364-7. PubMed ID: 6090665
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart.
Shryock JC; Travagli HC; Belardinelli L
J Pharmacol Exp Ther; 1992 Mar; 260(3):1292-9. PubMed ID: 1545393
[TBL] [Abstract][Full Text] [Related]
40. A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
Evoniuk G; Jacobson KA; Shamim MT; Daly JW; Wurtman RJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):882-7. PubMed ID: 3656117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
